PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas
Utility of PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Treatment of High Grade Sarcomas
Sponsor: UNC Lineberger Comprehensive Cancer Center
A NA clinical study on Sarcoma, this trial is completed. The trial is conducted by UNC Lineberger Comprehensive Cancer Center and has accumulated 11 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Dec 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Apr 2021 — Dec 2021 [monthly]
Completed NA
-
Jan 2021 — Apr 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
Mar 2020 — Jan 2021 [monthly]
Recruiting NA
-
Dec 2018 — Mar 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Dec 2018 [monthly]
Not Yet Recruiting NA
-
Apr 2017 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- UNC Lineberger Comprehensive Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .